Menlo Therapeutics Operating Income

Menlo Therapeutics (MNLO) currently reports a operating income of $-110M as of September 2020. That compares with $-73M in the prior-year period — down 55.9% year over year. Use the charts on this page to explore Menlo Therapeutics's operating income history and peer comparisons.

Menlo Therapeutics's operating income decreased from $-73M to $-110M — a 55.9% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Menlo Therapeutics reported $-110M in operating income as of September 2020. That compares with $-73M in the prior-year period — down 55.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Menlo Therapeutics, and consider following MNLO for alerts when major investors trade the stock.

Menlo Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MNLO with unrelated industries.